dc.contributor.author | Fedeles, Bogdan I | |
dc.contributor.author | Chawanthayatham, Supawadee | |
dc.contributor.author | Croy, Robert G | |
dc.contributor.author | Wogan, Gerald N | |
dc.contributor.author | Essigmann, John M | |
dc.date.accessioned | 2018-09-07T13:14:04Z | |
dc.date.available | 2018-09-07T13:14:04Z | |
dc.date.issued | 2017-07 | |
dc.date.submitted | 2017-05 | |
dc.identifier.issn | 2372-3556 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/117661 | |
dc.description.abstract | Using duplex-consensus sequencing technology, we recently identified the characteristic high-resolution mutational spectrum of the liver carcinogen aflatoxin B₁ in a mouse model, many months before aflatoxin-induced tumors are detectable. The diagnostic power of this spectrum is then demonstrated by accurately identifying, among the sequenced human liver tumors, the subset of cancers associated with aflatoxin B₁ exposure. Keywords: Duplex sequencing; HCC; hepatocellular carcinoma; mutagenesis; mutational signature; mycotoxins | en_US |
dc.publisher | Informa UK Limited | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1080/23723556.2017.1329693 | en_US |
dc.rights | Creative Commons Attribution-NonCommercial-NoDerivs License | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
dc.source | Taylor & Francis | en_US |
dc.title | Early Detection of the Aflatoxin B₁ Mutational Fingerprint: A Diagnostic Tool for Liver Cancer | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Fedeles, Bogdan I. et al. “Early Detection of the Aflatoxin B₁ Mutational Fingerprint: A Diagnostic Tool for Liver Cancer.” Molecular & Cellular Oncology 4, 4 (May 2017): e1329693 © 2017 The Author(s) | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Center for Environmental Health Sciences | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biological Engineering | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Chemistry | en_US |
dc.contributor.mitauthor | Fedeles, Bogdan I | |
dc.contributor.mitauthor | Chawanthayatham, Supawadee | |
dc.contributor.mitauthor | Croy, Robert G | |
dc.contributor.mitauthor | Wogan, Gerald N | |
dc.contributor.mitauthor | Essigmann, John M | |
dc.relation.journal | Molecular & Cellular Oncology | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2018-08-28T18:23:37Z | |
dspace.orderedauthors | Fedeles, Bogdan I.; Chawanthayatham, Supawadee; Croy, Robert G.; Wogan, Gerald N.; Essigmann, John M. | en_US |
dspace.embargo.terms | N | en_US |
dc.identifier.orcid | https://orcid.org/0000-0001-5252-826X | |
dc.identifier.orcid | https://orcid.org/0000-0003-0176-1920 | |
dc.identifier.orcid | https://orcid.org/0000-0003-0771-9889 | |
dc.identifier.orcid | https://orcid.org/0000-0002-2196-5691 | |
mit.license | PUBLISHER_CC | en_US |